ConductScience.org, home

Paper41208856

Enhanced pharmacokinetic and therapeutic of GSH-responsive mPEG-b-P(HPMA)-SGI1776 conjugate for osteosarcoma.

Shi X and 6 others. Front Pharmacol, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Enhanced pharmacokinetic and therapeutic of GSH-responsive mPEG-b-P(HPMA)-SGI1776 conjugate for osteosarcoma. Papers, record 41208856. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41208856

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhanced pharmacokinetic and therapeutic of GSH-responsive mPEG-b-P(HPMA)-SGI1776 conjugate for osteosarcoma.
PubMed
Journal
Front Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-11-12
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shi XXingchen
2Wang RRourou
3Zhang ZZhenghua
4Wang ZZixuan
5Xu WWeibing
6Shi XXinhe
7Geng ZZhe

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129313017Anticancer nanoparticulate polymer-drug conjugate.Bioeng Transl Med2016https://conductscience.org/library/papers/29313017PubMed
219491032HPMA-based polymer conjugates with drug combination.Eur J Pharm Sci2009https://conductscience.org/library/papers/19491032PubMed
338169995Combination of Chlorambucil and Mercaptopurine Show Effective Anti-Cancer Effects in Mice Model.Int J Nanomedicine2023https://conductscience.org/library/papers/38169995PubMed
436214740Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms.Expert Opin Drug Deliv2022https://conductscience.org/library/papers/36214740PubMed
540740117Tumor-responsive nanomedicines for cancer therapy: design principles and therapeutic advances.Biomed Mater2025https://conductscience.org/library/papers/40740117PubMed
639247254Biodegradable Zwitterionic Polymers as PEG Alternatives for Drug Delivery.J Polym Sci (2020)2024https://conductscience.org/library/papers/39247254PubMed
728681981ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy.Adv Mater2017https://conductscience.org/library/papers/28681981PubMed
829296558Advances in limb salvage treatment of osteosarcoma.J Bone Oncol2018https://conductscience.org/library/papers/29296558PubMed
923673544Osteosarcoma: review of the various types with emphasis on recent advancements in imaging.Semin Musculoskelet Radiol2013https://conductscience.org/library/papers/23673544PubMed
1030270668Regulation of insulin resistance and glucose metabolism by interaction of PIM kinases and insulin receptor substrates.Arch Physiol Biochem2020https://conductscience.org/library/papers/30270668PubMed
1128260965Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles.J Nanopart Res2017https://conductscience.org/library/papers/28260965PubMed
1230718520PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism.Cell Death Dis2019https://conductscience.org/library/papers/30718520PubMed
1329191047Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery - comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution.Drug Deliv2017https://conductscience.org/library/papers/29191047PubMed
1424925051Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity.Mod Pathol2014https://conductscience.org/library/papers/24925051PubMed
1530546919Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics.J Pharm Investig2018https://conductscience.org/library/papers/30546919PubMed
1634927373Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy.Adv Sci (Weinh)2022https://conductscience.org/library/papers/34927373PubMed
1727783140
Lower limb reconstruction in tumor patients using modular silver-coated megaprostheses with regard to perimegaprosthetic joint infection: a case series, including 100 patients and review of the literature.
Arch Orthop Trauma Surg2017https://conductscience.org/library/papers/27783140PubMed
1840164682Pim1 promotes the maintenance of bone homeostasis by regulating osteoclast function.Exp Mol Med2025https://conductscience.org/library/papers/40164682PubMed
1928195032pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.Drug Deliv2017https://conductscience.org/library/papers/28195032PubMed
2033662457Design and synthesis of a novel mitochondria-targeted osteosarcoma theranostic agent based on a PIM1 kinase inhibitor.J Control Release2021https://conductscience.org/library/papers/33662457PubMed

See all 33 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41208856

GET https://conductscience.org/api/papers/v1/41208856/references?page=2